MedPage Today on MSN
How much efficacy do statin users demand in primary prevention?
Study indicates daunting numbers ...
Q4 2025 Earnings Call February 18, 2026 4:30 PM ESTCompany ParticipantsSam Ramraj - Vice President of Investor ...
The BEE’s draft, scheduled for submission to the PMO on Monday, goes against SIAM’s submission which showed easing targets for lighter vehicles. Society of Indian Automobile Manufacturers (SIAM) has ...
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2025 Earnings Call Transcript February 24, 2026 Kiniksa Pharmaceuticals, Ltd.
Good morning, ladies and gentlemen, and welcome to the freenet AG Conference Call on the Preliminary Results for the Financial Year 2025. At this time, all participants are on a listen-only mode. The ...
Official statistics, state rankings, common crimes, death rates & regional security explained comprehensively.
6dOpinion
Dirty Business true story
The Channel 4 factual drama, starring Jason Watkins and David Thewlis, delivers a damning indictment of the decline of ...
Kiniksa Pharmaceuticals(NASDAQ:KNSA) highlighted rapid ARCALYST revenue expansion and expanding treatment adoption across its addressable pericarditis market. The transition from net loss to net ...
UK CFOs want finance automation but 66% still use Excel. Compare Sage Intacct AI agents vs Dynamics 365 Finance Copilot — ...
JELD-WEN Holding, Inc. (NYSE: JELD) ("JELD-WEN" or the "Company") today announced results for the three months and year ended ...
Potential First and Only Therapy in the EU for Ultra-Rare Immune Disorder - BOSTON, Feb. 27, 2026 (GLOBE NEWSWIRE) -- X4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results